DE60109594D1 - R-eliprodil zur behandlung von glaucoma - Google Patents
R-eliprodil zur behandlung von glaucomaInfo
- Publication number
- DE60109594D1 DE60109594D1 DE60109594T DE60109594T DE60109594D1 DE 60109594 D1 DE60109594 D1 DE 60109594D1 DE 60109594 T DE60109594 T DE 60109594T DE 60109594 T DE60109594 T DE 60109594T DE 60109594 D1 DE60109594 D1 DE 60109594D1
- Authority
- DE
- Germany
- Prior art keywords
- eliprodil
- glaucoma
- treatment
- treating glaucoma
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000010412 Glaucoma Diseases 0.000 title abstract 3
- 229950005455 eliprodil Drugs 0.000 title 1
- GGUSQTSTQSHJAH-FQEVSTJZSA-N (R)-eliprodil Chemical compound C([C@H](O)C=1C=CC(Cl)=CC=1)N(CC1)CCC1CC1=CC=C(F)C=C1 GGUSQTSTQSHJAH-FQEVSTJZSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20335000P | 2000-05-10 | 2000-05-10 | |
| PCT/US2001/015169 WO2001085169A2 (en) | 2000-05-10 | 2001-05-10 | R-eliprodil for treating glaucoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60109594D1 true DE60109594D1 (de) | 2005-04-28 |
Family
ID=22753611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60109594T Expired - Lifetime DE60109594D1 (de) | 2000-05-10 | 2001-05-10 | R-eliprodil zur behandlung von glaucoma |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1280528B1 (de) |
| JP (1) | JP2004521065A (de) |
| AT (1) | ATE291425T1 (de) |
| AU (2) | AU2001261360A1 (de) |
| CA (1) | CA2406549A1 (de) |
| DE (1) | DE60109594D1 (de) |
| WO (2) | WO2001085152A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2455896A1 (en) * | 2001-08-29 | 2003-03-13 | Alcon, Inc. | Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma |
| US6884816B2 (en) | 2001-08-31 | 2005-04-26 | Alcon, Inc. | Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma |
| EP1581209A4 (de) | 2002-12-13 | 2009-03-11 | Alcon Inc | Neue benzopyran-analoga und ihre verwendung zur behandlung von glaukom |
| WO2005053688A1 (en) | 2003-11-26 | 2005-06-16 | Alcon, Inc. | Substituted furo[2,3-g] indazoles for the treatment of glaucoma |
| TW200520760A (en) | 2003-12-15 | 2005-07-01 | Alcon Inc | Substituted [1,4] oxazino [2,3-g] indazoles for the treatment of glaucoma |
| US7338972B1 (en) | 2003-12-15 | 2008-03-04 | Alcon, Inc. | Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2628740B3 (fr) * | 1989-04-12 | 1990-01-19 | Synthelabo | Procede de preparation des enantiomeres du (chloro-4 phenyl)-1 (((fluoro-4 phenyl)methyl)-4 piperidyl-1)-2 ethanol |
| FR2654341B1 (fr) * | 1989-11-14 | 1994-09-23 | Synthelabo | Utilisation d'ifenprodil et de ses derives pour la fabrication de medicaments antipsychotiques. |
| US5710165A (en) * | 1994-07-06 | 1998-01-20 | Synthelabo | Use of polyamine antagonists for the treatment of glaucoma |
| CA2237898A1 (en) * | 1995-11-17 | 1997-05-29 | Louis Desantis Jr. | Combination therapy for treating glaucoma |
| WO2000004898A1 (en) * | 1998-07-21 | 2000-02-03 | Merck & Co., Inc. | Ophthalmic compositions for treating ocular hypertension |
| WO2000004899A1 (en) * | 1998-07-21 | 2000-02-03 | Merck & Co., Inc. | Ophthalmic compositions for treating ocular hypertension |
-
2001
- 2001-05-09 WO PCT/US2001/015074 patent/WO2001085152A2/en not_active Ceased
- 2001-05-09 AU AU2001261360A patent/AU2001261360A1/en not_active Abandoned
- 2001-05-10 WO PCT/US2001/015169 patent/WO2001085169A2/en not_active Ceased
- 2001-05-10 AU AU2001263042A patent/AU2001263042A1/en not_active Abandoned
- 2001-05-10 JP JP2001581823A patent/JP2004521065A/ja not_active Withdrawn
- 2001-05-10 CA CA002406549A patent/CA2406549A1/en not_active Abandoned
- 2001-05-10 AT AT01937291T patent/ATE291425T1/de not_active IP Right Cessation
- 2001-05-10 EP EP01937291A patent/EP1280528B1/de not_active Expired - Lifetime
- 2001-05-10 DE DE60109594T patent/DE60109594D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001263042A1 (en) | 2001-11-20 |
| WO2001085152A3 (en) | 2002-03-28 |
| AU2001261360A1 (en) | 2001-11-20 |
| ATE291425T1 (de) | 2005-04-15 |
| WO2001085169A3 (en) | 2002-03-28 |
| EP1280528B1 (de) | 2005-03-23 |
| JP2004521065A (ja) | 2004-07-15 |
| WO2001085169A2 (en) | 2001-11-15 |
| CA2406549A1 (en) | 2001-11-15 |
| WO2001085152A2 (en) | 2001-11-15 |
| EP1280528A2 (de) | 2003-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20054988D0 (no) | Preparater og metoder for behandling av cancer | |
| ATE350030T1 (de) | Nordihydroguaiaretinsäurederivate zur behandlung von tumoren | |
| ATE320803T1 (de) | Verfahren zur behandlung von alzheimerschen krankheit | |
| DE60015070D1 (de) | Verwendung von antikonvulsiven derivaten zur behandlung der cluster headache | |
| DE60022692D1 (de) | (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen | |
| DE60120667D1 (de) | Methoden und mittel zur behandlung von bandscheibenverschleiss | |
| DE60330161D1 (de) | Rifalazil zur behandlung von infektionen mit clostridium difficile | |
| CY1107531T1 (el) | Χρηση αναστολεων πρωτεασομης για την αγωγη των διαταραχων ξηρου οφθαλμου | |
| ATE415163T1 (de) | Verfahren und zusammensetzungen zur behandlung von augenerkrankungen | |
| ATE541565T1 (de) | Topische verwendung von muskarinischen und opioiden mitteln zur behandlung von tinnitus | |
| EP1506001A4 (de) | Verfahren und zusammensetzungen zur behandlung von epithelläsionen in vagina, zervix und uterus | |
| DE60206289D1 (de) | Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne | |
| DE50108409D1 (de) | Behandlung von oberflächen zur temporären verbesserung des schmutzablöseverhaltens | |
| SI1441761T1 (sl) | Postopki za preprečevanje in zdravljenje flavivirusne infekcije pri živalih | |
| DE50114605D1 (de) | No-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz | |
| ATE291425T1 (de) | R-eliprodil zur behandlung von glaucoma | |
| DE60125212D1 (de) | Verwendung von Aivlosin zur Behandlung und Prevention der Lawsonia-Infektionen in Schweinen. | |
| ATE359808T1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
| ATE422944T1 (de) | Superoxiddismutas-mimetika zur behandlung von augenerkrankungen | |
| ATE406171T1 (de) | Aplidine zur behandlung von multiplem myelom | |
| DE60142786D1 (de) | Zusammensetzungen und methoden zur behandlung von candidosen | |
| DE69818809D1 (de) | Verfahren zur behandlung von narbengewebe | |
| DE60144493D1 (de) | Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen | |
| ATE548048T1 (de) | Oncomodulin zur behandlung von neurologishen erkrankungen | |
| ATE278401T1 (de) | Verwendung von riluzol zur behandlung von akustischen traumazuständen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8332 | No legal effect for de |